COVAX to purchase 40 mln doses of Pfizer-BioNTech vaccine: WHO

GENEVA, Jan. 22 (Xinhua) -- COVAX, the global initiative led by the World Health Organization (WHO) to ensure rapid and equitable access to COVID-19 vaccines for all countries, said on Friday that it will purchase up to 40 million doses of the Pfizer-BioNTech vaccine.

Rollout of the Pfizer-BioNTech vaccine, which has already received WHO emergency use listing, will commence with the successful negotiation and execution of supply agreements, according to a COVAX announcement.